Adage Capital Partners’s Nuvation Bio Inc Warrants NUVB.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-266,666
| Closed | -$88K | – | 1038 |
|
|
2025
Q4 | $88K | Hold |
266,666
| – | – | ﹤0.01% | 894 |
|
|
2025
Q3 | $53.9K | Hold |
266,666
| – | – | ﹤0.01% | 863 |
|
|
2025
Q2 | $72K | Hold |
266,666
| – | – | ﹤0.01% | 835 |
|
|
2025
Q1 | $85.3K | Hold |
266,666
| – | – | ﹤0.01% | 825 |
|
|
2024
Q4 | $61.3K | Hold |
266,666
| – | – | ﹤0.01% | 859 |
|
|
2024
Q3 | $26.1K | Hold |
266,666
| – | – | ﹤0.01% | 838 |
|
|
2024
Q2 | $42.7K | Hold |
266,666
| – | – | ﹤0.01% | 832 |
|
|
2024
Q1 | $80.7K | Hold |
266,666
| – | – | ﹤0.01% | 832 |
|
|
2023
Q4 | $16K | Hold |
266,666
| – | – | ﹤0.01% | 827 |
|
|
2023
Q3 | $26.7K | Hold |
266,666
| – | – | ﹤0.01% | 843 |
|
|
2023
Q2 | $44.1K | Hold |
266,666
| – | – | ﹤0.01% | 833 |
|
|
2023
Q1 | $32K | Hold |
266,666
| – | – | ﹤0.01% | 893 |
|
|
2022
Q4 | $38.5K | Hold |
266,666
| – | – | ﹤0.01% | 919 |
|
|
2022
Q3 | $53K | Hold |
266,666
| – | – | ﹤0.01% | 987 |
|
|
2022
Q2 | $75K | Hold |
266,666
| – | – | ﹤0.01% | 1015 |
|
|
2022
Q1 | $215K | Hold |
266,666
| – | – | ﹤0.01% | 999 |
|
|
2021
Q4 | $504K | Hold |
266,666
| – | – | ﹤0.01% | 929 |
|
|
2021
Q3 | $683K | Hold |
266,666
| – | – | ﹤0.01% | 927 |
|
|
2021
Q2 | $693K | Hold |
266,666
| – | – | ﹤0.01% | 922 |
|
|
2021
Q1 | $712K | Buy |
+266,666
| New | +$771K | ﹤0.01% | 899 |
|
Adage Capital Partners's NUVB.WS Position: Q1 2026 in Review
Adage Capital Partners sold out of Nuvation Bio Inc Warrants (NUVB.WS) in Q1 2026, closing a stake of 266,666 shares — an estimated $88K sold.
Adage Capital Partners first reported a position in NUVB.WS in Q1 2021 and held it in 20 quarters. The position peaked at $712K in Q1 2021. 0 funds tracked by Wall St. Rank hold NUVB.WS as of Q1 2026.
- Adage Capital Partners reported no remaining Nuvation Bio Inc Warrants position as of Q1 2026 after selling out during the quarter.
- Adage Capital Partners sold 266,666 Nuvation Bio Inc Warrants shares in Q1 2026, an estimated $88K.
- Adage Capital Partners first reported a position in Nuvation Bio Inc Warrants in Q1 2021 and held it in 20 quarters.
- Adage Capital Partners's Nuvation Bio Inc Warrants position peaked at $712K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Nuvation Bio Inc Warrants as of Q1 2026.
Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.